Showing results (51-60 of 124) with videos related to
Sort By:
Pageof 13
Cancer|February 15, 1985
Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycinG N Pillai, F B Hagemeister, W S Velasquez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphomaP McLaughlin, F B Hagemeister, F Swan, et al.Investigational New Drugs|January 19, 2000
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combinationJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.Blood|June 1, 1988
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyteF Cabanillas, S Pathak, J Trujillo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyF B Hagemeister, R Purugganan, D A Podoloff, et al.International Journal of Radiation Oncology, Biology, Physics|June 1, 1997
Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progressionM T Vlachaki, F B Hagemeister, L M Fuller, et al.International Journal of Radiation Oncology, Biology, Physics|March 4, 2000
Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP)P Dubey, G Wilson, K K Mathur, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenaseJ Rodriguez, W C Pugh, J E Romaguera, et al.International Journal of Radiation Oncology, Biology, Physics|August 27, 1998
Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factorsZ Liao, C S Ha, L M Fuller, et al.Cancer|December 1, 1982
Treatment of patients with stages I and II nonmediastinal Hodgkin's diseaseF B Hagemeister, L M Fuller, J A Sullivan, et al.Pageof 13